29 December 2024 : Clinical Research
Prospective Analysis of Central Nervous System Infection Risks in Varicella-Zoster Virus Reactivation Cases: A Single-Center Prospective Study of 1030 Cases
Jun Wang ABEG 1*, Yanrong Yuan BEF 1, Huili Liu BCF 1, Yan Zhang EF 1, Yongxing Yan ACDG 1DOI: 10.12659/MSM.945835
Med Sci Monit 2024; 30:e945835
Table 4 Comparison of serum marker levels between the 2 groups (x±SD).
| HZ group (n=990) | VZV-associated CNS infection group (n=40) | t | P | |
|---|---|---|---|---|
| K+ (mmol/L) | 4.0±1.3 | 4.0±0.4 | 0.048 | 0.962 |
| Na+ (mmol/L) | 139.8±9.2 | 139.2±3.6 | 0.452 | 0.652 |
| Cl− (mmol/L) | 102.4±3.6 | 101.2±3.9 | 2.003 | 0.045 |
| Ca++ (mmol/L) | 2.2±0.6 | 2.2±0.1 | 0.520 | 0.604 |
| P+++ (mmol/L) | 1.1±0.2 | 1.2±0.2 | 0.919 | 0.358 |
| Mg++ (mmol/L) | 0.8±0.3 | 0.8±0.1 | 0.102 | 0.919 |
| Fe+++ (μmol/L) | 12.8±6.9 | 13.3±7.1 | 0.348 | 0.728 |
| Unsaturated iron binding force (μmol/L) | 35.9±8.7 | 34.6±7.1 | 0.828 | 0.408 |
| Total iron binding capacity (μmol/L) | 48.5±7.9 | 48.2±7.6 | 0.177 | 0.860 |
| Transferrin (g/L) | 2.1±0.8 | 2.1±0.4 | 0.067 | 0.947 |